Dr. Albert Bourla is also troubled by this trend — and few people are more personally connected to the topic. Bourla is the son of two Holocaust survivors, and he is the CEO and chairman of ...

"And I, you know what I think that Dr. Bourla, he's done a lot of good worldwide. He's done many things that I think are very positive for healthcare. I think that the issue has been, what about ...

The firm aims to deliver as much as $4 billion in 2024 cost savings. Cramer’s remarks surrounded Dr. Bourla’s relationship and potential meeting with President-elect Trump: “Dr. Bourla ...

Dr. Bourla received the largest number of votes in a recently concluded global campaign, during which 200,000 people in 71 countries voted online. The choice of the voters was unanimously endorsed ...

CEO Albert Bourla expressed modest optimism for Pfizer’s 2025 revenues at JPM 2025, supported by plans to prioritize R&D in ...

Dr. Albert Bourla, Pfizer (PFE) Chairman and CEO, stated: “Pfizer is in a strong position to continue making a positive impact for patients and delivering on our financial commitments in 2025.

Bourla said the experts were helping Pfizer "make better and more sound decisions," and the company could start a late-stage study of its drug, danuglipron, in the second half of this year.

We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim ...

(Reuters) -U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...

We recently published a list of the Jim Cramer Just Discussed These 13 Stocks. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other stocks that Jim Cramer ...